Director Medical Affairs
Regeneron Pharmaceuticals
Summary
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Director of Medical Affairs, Hematology to join our Medical Affairs team, supporting our Hematology portfolio. In this role, you will shape medical strategy and evidence generation while serving as a key scientific and medical resource, collaborating with colleagues in Medical Affairs, Research & Development, Commercial, and Patient Advocacy, as well as external healthcare practitioners, research groups, payers, and alliance partners.
Job description
When & Where
- Location: Sleepy Hollow, NY
- Work model: On-site 4 days/week
- Travel: up to 20%
Discover Your Role
- Define medical strategy, set annual goals, and ensure compliant execution of Medical Affairs activities
- Serve as a key scientific and medical resource with deep knowledge of the Hematology disease area
- Lead the cross-functional Medical Product Team (MPT) in a matrix environment
- Shape evidence generation strategy and oversee Phase 3B/4 studies, both interventional and observational
- Guide publications and presentations in partnership with the Publication Manager
- Engage the external scientific community to advance understanding of disease management, standards of care, and the role of our medicines
- Develop medical content for congresses, symposia, and advisory boards, and lead these activities
- Present scientific and medical information to diverse audiences, including physicians, pharmacists, and agency partners
This Role Requires
- MD or equivalent, PhD, or PharmD degree
- 5+ years of biotech or pharmaceutical industry experience in Medical Affairs
- Clinical research and/or drug development experience in Hematology/Oncology or Oncology is required
- Launch experience, publication track record, matrix leadership is preferred
Requirements
- MD or equivalent, PhD, or PharmD degree
- 5+ years of biotech or pharmaceutical industry experience in Medical Affairs
- Clinical research and/or drug development experience in Hematology/Oncology or Oncology is required
- Launch experience, publication track record, matrix leadership is preferred
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Medical insurance
- Dental insurance
- Vision insurance
- Life and disability insurance
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.